L_5_06

Genetic Adaptation to Disease: Malaria, Plague, TB

Verified (Tier 1)
Confidence: 4/5 Section: L Updated: March 11, 2026
Source Count: 14 | Weighted Score: 39 | Source Confidence: [4/5] | Primary Tier: 1 | Last Updated: March 11, 2026
Keywords: natural selection, disease adaptation, malaria, sickle cell, G6PD, Duffy antigen, plague, Black Death, CCR5-delta32, tuberculosis, HLA, pathogen-driven selection, balancing selection, heterozygote advantage, resistance allele
Category Tags: genetics, natural-selection, disease-adaptation, malaria, plague, pathogen, HLA
Cross-References: L_3_09 — HLA Diversity · Z_4_13 — Infectious Disease Biology · X_1_01 — Epidemics and History · L_4_13 — Ancient DNA Methods

QUICK SUMMARY

Infectious disease has been the most powerful selective force on the human genome throughout history. Pathogens — particularly malaria, plague, tuberculosis, smallpox, and cholera — have killed more humans than all other causes combined, and the relentless evolutionary arms race between human hosts and microbial parasites has left deep signatures across the genome. The most dramatic example is the cluster of genetic defenses against malaria (Plasmodium falciparum): the sickle cell trait (heterozygous HbS — providing ~90% protection against severe malaria through polymerization of deoxygenated hemoglobin that kills parasitized red blood cells), glucose-6-phosphate dehydrogenase (G6PD) deficiency (protective through oxidative stress in infected cells — the most common enzyme deficiency in the world, affecting ~400 million people), Duffy-negative blood group (homozygous DARC mutation eliminating the P. vivax receptor on red blood cells — nearly universal in sub-Saharan Africa, providing complete resistance to P. vivax), thalassemia (alpha and beta — reduced hemoglobin production that confers malaria resistance in heterozygotes), and hemoglobin C and E variants. These defenses all exhibit balancing selection — heterozygotes are protected against malaria while homozygotes suffer disease (sickle cell disease, severe G6PD deficiency, thalassemia major) — illustrating the evolutionary trade-off between infection resistance and genetic disease. The 2011 and 2014 ancient DNA studies of Black Death (Yersinia pestis, 1346-1353) victims by Bos, Krause, and colleagues demonstrated that the medieval plague bacterium was genomically nearly identical to modern strains — suggesting that the ~30-60% mortality of the Black Death was driven by immunological naivety rather than a uniquely virulent pathogen. Klunk et al. (2022) analyzed aDNA from pre- and post-plague London and found that the plague exerted strong selection on immune genes — including genes near ERAP2 (which processes peptides for HLA-I presentation), with protective alleles increasing in frequency by ~10% in a single generation. The CCR5-Δ32 deletion (which eliminates the CCR5 co-receptor used by HIV to enter cells) was long thought to have been selected by plague or smallpox — but its pre-plague frequency in aDNA suggests a more complex selection history. Across the genome, HLA diversity — the extraordinary polymorphism of the major histocompatibility complex — is maintained by pathogen-driven balancing selection: populations in regions with greater pathogen diversity carry greater HLA diversity, and specific HLA alleles are associated with resistance or susceptibility to particular infections.


1. VERIFIED CLAIMS (Tier 1 — Peer-Reviewed / Established)

1.1 Malaria as Selective Agent

1.2 HLA Diversity and Pathogens

1.3 Black Death Ancient DNA


2. CREDIBLE CLAIMS (Tier 2 — Academic / Debated but Supported)

2.1 Plague-Driven Selection on Immune Genes

2.2 CCR5-Δ32 Selection History

2.3 Tuberculosis and Natural Selection


3. SPECULATIVE CLAIMS (Tier 3 — Possible but Unverified)

3.1 Autoimmune Disease as a Cost of Pathogen Resistance

3.2 Smallpox as a Major Selective Agent


4. DUBIOUS CLAIMS (Tier 4 — No Credible Source / Contradicted by Evidence)

4.1 CCR5-Δ32 Was Selected by the Black Death

4.2 Genetic Immunity Makes Vaccines Unnecessary


COUNTER-ARGUMENTS

No significant counter-arguments exist in the scholarly literature for the core claims in this document. The genetic adaptation to infectious disease (malaria, plague, tuberculosis) represents established scientific consensus with no active scholarly dispute over the fundamental claims presented here.


IMAGES

#DescriptionFilenameSourceLicense

No images assigned yet.


BIBLIOGRAPHY

  1. Allison, A.C | 1954 | "Protection Afforded by Sickle-Cell Trait against Subtertian Malarial Infection" | British Medical Journal | ∅ | 1.4857::290–294 | ∅ | ∅ | doi:10.1136/bmj.1.4857.290 | ∅ | ∅ | ∅
  2. Kwiatkowski, Dominic P | 2005 | "How Malaria Has Affected the Human Genome and What Human Genetics Can Teach Us about Malaria" | American Journal of Human Genetics | ∅ | 77.2::171–192 | ∅ | ∅ | doi:10.1086/432519 | ∅ | ∅ | ∅
  3. Prugnolle, Franck, et al | 2005 | "Pathogen-Driven Selection and Worldwide HLA Class I Diversity" | Current Biology | ∅ | 15.11::1022–1027 | ∅ | ∅ | doi:10.1016/j.cub.2005.04.050 | ∅ | ∅ | ∅
  4. Bos, Kirsten I., et al | 2011 | "A Draft Genome of Yersinia pestis from Victims of the Black Death" | Nature | ∅ | 478.7370::506–510 | ∅ | ∅ | doi:10.1038/nature10549 | ∅ | ∅ | ∅
  5. Klunk, Jennifer, et al | 2022 | "Evolution of Immune Genes Is Associated with the Black Death" | Nature | ∅ | 611.7935::312–319 | ∅ | ∅ | doi:10.1038/s41586-022-05349-x | ∅ | ∅ | ∅
  6. Miller, Louis H., Susan J | 1976 | "The Resistance Factor to Plasmodium vivax in Blacks: The Duffy-Blood-Group Genotype, FyFy" | New England Journal of Medicine | ∅ | 295.6::302–304 | Mason, David F | ∅ | ∅ | ∅ | ∅ | Clyde, and McGehee H; McGinniss
  7. Fumagalli, Matteo, et al. e1002355 | 2011 | "Signatures of Environmental Genetic Adaptation Pinpoint Pathogens as the Main Selective Pressure through Human Evolution" | PLOS Genetics | ∅ | 7.11:: | ∅ | ∅ | ∅ | ∅ | ∅ | ∅
  8. Comas, Iñaki, et al | 2013 | "Out-of-Africa Migration and Neolithic Coexpansion of Mycobacterium tuberculosis with Modern Humans" | Nature Genetics | ∅ | 45.10::1176–1182 | ∅ | ∅ | ∅ | ∅ | ∅ | ∅
  9. Quintana-Murci, Lluís; Andrew G | 2013 | "Population Genetic Tools for Dissecting Innate Immunity in Humans" | Nature Reviews Immunology | ∅ | 13.4::280–293 | Clark | ∅ | ∅ | ∅ | ∅ | ∅
  10. Hedrick, Philip W | 2011 | "Population Genetics of Malaria Resistance in Humans" | Heredity | ∅ | 107.4::283–304 | ∅ | ∅ | ∅ | ∅ | ∅ | ∅
  11. Sabeti, Pardis C., et al | 2002 | "Detecting Recent Positive Selection in the Human Genome from Haplotype Structure" | Nature | ∅ | 419.6909::832–837 | ∅ | ∅ | ∅ | ∅ | ∅ | ∅
  12. Karlsson, Elinor K., Dominic P | 2014 | "Natural Selection and Infectious Disease in Human Populations" | Nature Reviews Genetics | ∅ | 15.6::379–393 | Kwiatkowski, and Pardis C | ∅ | ∅ | ∅ | ∅ | Sabeti
  13. Luzzatto, Lucio. e2012065 | 2012 | "Sickle Cell Anaemia and Malaria" | Mediterranean Journal of Hematology and Infectious Diseases | ∅ | 4.1:: | ∅ | ∅ | ∅ | ∅ | ∅ | ∅
  14. Spyrou, Maria A., et al | 2022 | "The Source of the Black Death in Fourteenth-Century Central Eurasia" | Nature | ∅ | 606.7915::718–724 | ∅ | ∅ | ∅ | ∅ | ∅ | ∅

CROSS-REFERENCE INDEX

Related DocConnection
L_3_09HLA diversity
Z_4_13Infectious disease biology
X_1_01Epidemics and history
L72Ancient pathogen genomics

Generated from V4 expansion plan. Last Updated: March 11, 2026


⚠️ AI-Assisted Research Disclaimer

This document was generated and structured with the assistance of AI tools.

While every effort is made to ensure accuracy, AI-assisted content may

contain errors, misattributions, or unintended inaccuracies. Always verify claims, dates, and sources independently before citing or relying

on any information presented here.

  • Sources may contain errors. Bibliography entries and cross-references

are checked by automated systems, but mistakes can occur. If something

looks wrong, it may be.

  • Speculative and unverified claims are clearly labeled. This project

uses a four-tier evidence system:

  • Tier 1 — Verified: Peer-reviewed, established scientific consensus.
  • Tier 2 — Credible: Academically supported, debated but grounded.
  • Tier 3 — Speculative: Plausible but unverified by mainstream science.
  • Tier 4 — Dubious: No credible support or contradicted by evidence.
  • This project maps multiple perspectives — not a single truth. Mainstream,

alternative, and skeptical viewpoints are presented side by side for

critical comparison, not endorsement. Inclusion does not imply agreement.

  • We are actively improving. Source verification, factuality scoring,

and bibliography enrichment are ongoing. Each revision adds stronger

citations, corrects identified errors, and expands coverage.

📖 For full details on our verification methodology, scoring systems, and

quality metrics, see: Fact-Checking & Verification Systems

Think Openly. Check the sources. Draw your own conclusions.